COMP <GO>
VREX vs CRCT // ENTERPRISE SCALE & MARKET CAP
Varex Imaging Corporation (NASDAQ) VS. Cricut Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: VREX 2
— CRCT 7
▲ ENTERPRISE SCALE & MARKET CAP LEADER: CRCT
LAST: $18.44 (-0.05%) • MKT CAP: $776.3M
market-cap
$776.3M
LAST: $6.18 (+1.81%) • MKT CAP: $1.29B
market-cap
$1.29B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VREX VS. CRCT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VREX | CRCT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 34.40% | 55.10% | -20.70 | CRCT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -3.00% | 85.00% | -88.00 | CRCT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 10.8x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.42% | 15.47% | -13.05 | CRCT | /fcf-yield <GO> |
| Operating Margin | -3.30% | 13.50% | -16.80 | CRCT | /operating-margins <GO> |
| Net Profit Margin | -8.30% | 10.80% | -19.10 | CRCT | /net-margins <GO> |
| Revenue Growth (YoY) | 4.10% | -0.50% | +4.60 | VREX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.96 | 5.62 | -3.66 | CRCT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.7 | 44.5 | +15.18 | VREX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 15.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $776.3M | $1.29B | -$518.0M | CRCT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VREX REV | CRCT REV | VREX GROSS % | CRCT GROSS % | VREX FCF | CRCT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $844.6M | $708.8M | 34.4% | 55.1% | $18.8M | $200.2M |
| FY 2024 | $811.0M | $712.5M | 31.7% | 49.5% | $20.4M | $265.0M |
| FY 2023 | $893.4M | $765.1M | — | — | $108.4M | $288.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VREX // BETA —
CRCT // BETA —